Back to Search Start Over

Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System.

Authors :
Panebianco, V
Briganti, A.
Boellaard, T.N.
Catto, J.
Comperat, E.
Efstathiou, J.
Heijden, A.G. van der
Giannarini, G.
Girometti, R.
Mertens, L.
Takeuchi, M.
Muglia, V.F.
Narumi, Y.
Novara, G.
Pecoraro, M.
Roupret, M.
Sanguedolce, F.
Santini, D.
Shariat, S.F.
Simone, G.
Vargas, H.A.
Woo, S.
Barentsz, J.
Witjes, J.A.
Panebianco, V
Briganti, A.
Boellaard, T.N.
Catto, J.
Comperat, E.
Efstathiou, J.
Heijden, A.G. van der
Giannarini, G.
Girometti, R.
Mertens, L.
Takeuchi, M.
Muglia, V.F.
Narumi, Y.
Novara, G.
Pecoraro, M.
Roupret, M.
Sanguedolce, F.
Santini, D.
Shariat, S.F.
Simone, G.
Vargas, H.A.
Woo, S.
Barentsz, J.
Witjes, J.A.
Source :
Nature Reviews. Urology, 21, 4, pp. 243-251
Publication Year :
2024

Abstract

Item does not contain fulltext<br />Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.<br />01 april 2024

Details

Database :
OAIster
Journal :
Nature Reviews. Urology, 21, 4, pp. 243-251
Publication Type :
Electronic Resource
Accession number :
edsoai.on1443486726
Document Type :
Electronic Resource